StocksAmgen IncAMGN

AMGN

Amgen Inc

227.72 -1.18 (-0.52%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
227.37
B
227.91

Overview

Prev Close227.72
Day's Range227.16 - 231.09
52 Week Range198.45 - 276.32
Average Volume (3m)2.81M
1-Year Return-10.28%
Beta0.7387
Market Cap128.27B
P/E Ratio23.47
Revenue25.77B
EPS9.7046
Dividend (Yield)8.98 (3.94%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.709/08/202121/10/202103/01/2022200.00210.00220.00230.00240.00250.00
Chart times in UTC
Industry Biotechnology
CEO Robert A. Bradway, MBA
Employees 24,300

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: Amgen Inc's revenues increased by 8.06% and amounted to 25.25B. Net income decreased by 7.37% to 7.26B. Net assets decreased by 2.73% to 9.41B and EPS decreased from 12.88 to 12.31.
AMGN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
75.43%
Net Profit Margin
26.62%
Operating Margin
34.35%
Return On Investment
15.39%
12/20
03/21
06/21
09/21
Total Revenue
6.61B
5.9B
6.53B
6.71B
Gross Profit
5.02B
4.41B
5.49B
5.7B
Operating Income
1.99B
2.13B
3.02B
3.43B
Net Income
1.62B
1.65B
464M
1.88B